Role of circulating tumour DNA in gastric cancer: a review
Circulating tumour DNA (ctDNA) represents an emerging liquid biopsy tool with significant clinical utility in gastric cancer detection, monitoring and prognostication. Multicancer early detection blood tests achieve 66.7% sensitivity for advanced disease and up to 81% for early-stage detection using methylation-based a...